Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.56 | 6.53 |
| PEG Ratio (TTM) | 0.09 | 0.01 |
| P/S Ratio (TTM) | 0.59 | 1.42 |
| P/B Ratio (TTM) | 0.51 | 1.02 |
| P/FCF Ratio (TTM) | -5.79 | -4.59 |
| Price to 5YR AVG Earnings Ratio | -3.04 | -4.39 |
| Price to 5YR AVG FCF Ratio | -9.05 | 10.52 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.51% | 8.36% |
| ROE (TTM) | -13.34% | 16.39% |
| Net Profit Margin (TTM) | -16.57% | 18.10% |
| ROIC 5YR AVG | -4.82% | 11.78% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -52.42% | 37.59% | -250.28% |
| Revenue | -1.66% | -9.88% | 5.22% |
| Net Income | -51.55% | 32.21% | -266.35% |
| Cash Flow | -117.51% | 10.25% | 64.30% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.63 | 1.69 |
| Quick Ratio (TTM) | 1.59 | 1.53 |
| D/E Ratio (TTM) | 0.93 | 0.60 |
| Interest Coverage (TTM) | -0.40 | 10.48 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.43 | 2.16 |
| LTL to 5YR AVG FCF | -16.12 | 5.91 |
| Shares Outstanding Growth 5YR AVG | 5.36% | 14.11% |